‘Poly-refractory’ disease affects 2.7% of patients with rheumatoid arthritis (RA) who have failed different groups of biologic disease-modifying antirheumatic drugs (b-DMARDS) and targeted synthetic ...
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III ...
Correspondence to Professor Sang-Won Lee, Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea (the Republic of); SANGWONLEE{at}yuhs.ac The mean age of the patients was 60.2 ...
Background The European Scleroderma Trials and Research Group (EUSTAR) recently developed a preliminarily revised activity index (AI) that performed better than the European Scleroderma Study Group ...
Background: Rowell syndrome is a rather rare and highly debated entity, initially defined by Rowell et all as discoid lupus associated with erythema multiforme-like (EM) lesions, positive speckled ANA ...
Correspondence to Dr. Kornelis S M van der Geest, Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9712 CP Groningen, Netherlands; ...
Background The SAPHO syndrome has to be considered as a rare subtype of the disease entity of the seronegative spondylarthritis. The characteristic defining symptoms are synovitis, acne, palmoplantar ...
Background Microplastics (MPs) have been identified in different types of tissue, including lung, bowel, placenta and as well in human whole blood [1]. During analysis of synovial fluid samples with ...
1 Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey 2 Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, ...
Correspondence to Kevin L Winthrop, MD, MPH, OHSU-PSU School of Public Health, 3181 S.W. Sam Jackson Rd, Portland, OR 97239, USA; winthrop{at}ohsu.edu Current American College of Rheumatology ...
1 AbbVie Bioresearch Center, Immunology Discovery, Worcester, United States of America 2 AbbVie Bioresearch Center, Biologics Discovery, Worcester, United States of America 3 AbbVie, Clinical ...